Nations Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
10,700
-500
| -4% | -$6.41K | 0.01% | 664 |
|
|
2025
Q1 | $142K | Sell |
11,200
-500
| -4% | -$6.35K | 0.01% | 638 |
|
|
2024
Q4 | $154K | Hold |
11,700
| – | – | 0.01% | 650 |
|
|
2024
Q3 | $176K | Hold |
11,700
| – | – | 0.01% | 650 |
|
|
2024
Q2 | $166K | Sell |
11,700
-300
| -3% | -$4.25K | 0.01% | 611 |
|
|
2024
Q1 | $164K | Hold |
12,000
| – | – | 0.01% | 604 |
|
|
2023
Q4 | $162K | Hold |
12,000
| – | – | 0.02% | 600 |
|
|
2023
Q3 | $150K | Sell |
12,000
-1,900
| -14% | -$23.7K | 0.02% | 592 |
|
|
2023
Q2 | $188K | Hold |
13,900
| – | – | 0.02% | 590 |
|
|
2023
Q1 | $194K | Hold |
13,900
| – | – | 0.02% | 587 |
|
|
2022
Q4 | $198K | Hold |
13,900
| – | – | 0.02% | 567 |
|
|
2022
Q3 | $190K | Buy |
13,900
+2,200
| +19% | +$30.1K | 0.03% | 510 |
|
|
2022
Q2 | $166K | Hold |
11,700
| – | – | 0.02% | 506 |
|
|
2022
Q1 | $194K | Hold |
11,700
| – | – | 0.02% | 501 |
|
|
2021
Q4 | $225K | Hold |
11,700
| – | – | 0.03% | 446 |
|
|
2021
Q3 | $243K | Buy |
+11,700
| New | +$243K | 0.04% | 397 |
|